Putting the antibiotics chloramphenicol and linezolid into context
Growing evidence suggests that many ribosome-targeting antibiotics inhibit protein synthesis context specifically, which has important implications for drug development. New work reveals the structural basis of context-specific action of the classic translation inhibitor chloramphenicol and the oxaz...
Gespeichert in:
| Veröffentlicht in: | Nature structural & molecular biology 2022-02, Vol.29 (2), p.79-81 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 81 |
|---|---|
| container_issue | 2 |
| container_start_page | 79 |
| container_title | Nature structural & molecular biology |
| container_volume | 29 |
| creator | Crowe-McAuliffe, Caillan Wilson, Daniel N. |
| description | Growing evidence suggests that many ribosome-targeting antibiotics inhibit protein synthesis context specifically, which has important implications for drug development. New work reveals the structural basis of context-specific action of the classic translation inhibitor chloramphenicol and the oxazolidinones linezolid and radezolid. |
| doi_str_mv | 10.1038/s41594-022-00725-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2629055768</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2629162660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-35c2ddc791316fd4f9de59255b3d08bc5b257582cfa6c19e960baa7330586e5b3</originalsourceid><addsrcrecordid>eNp9kM1PwyAchonRuDn9BzyYJl68VPkoUI66-JUs0YOeCaV0Y-lgFpqof724zpl48ATJ-_xefjwAnCJ4iSApr0KBqChyiHEOIcc053tgjGhBcyFKur-7CzICRyEsIcSUcnIIRoQiljI-BjfPfYzWzbO4MJly0VbWR6tDphet79RqvTDOat-mrM5a68ynb22dWRd9pr2L5j0eg4NGtcGcbM8JeL27fZk-5LOn-8fp9SzXhNOYE6pxXWsuEEGsqYtG1IaKtFFFalhWmlaYclpi3SimkTCCwUopTgikJTOJmoCLoXfd-bfehChXNmjTtsoZ3weJGRYwfZCVCT3_gy5937m03YZCDDMGE4UHSnc-hM40ct3Zleo-JILy27AcDMtkWG4MS56GzrbVfbUy9W7kR2kCyACEFLm56X7f_qf2C43fhgQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2629162660</pqid></control><display><type>article</type><title>Putting the antibiotics chloramphenicol and linezolid into context</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Nature</source><creator>Crowe-McAuliffe, Caillan ; Wilson, Daniel N.</creator><creatorcontrib>Crowe-McAuliffe, Caillan ; Wilson, Daniel N.</creatorcontrib><description>Growing evidence suggests that many ribosome-targeting antibiotics inhibit protein synthesis context specifically, which has important implications for drug development. New work reveals the structural basis of context-specific action of the classic translation inhibitor chloramphenicol and the oxazolidinones linezolid and radezolid.</description><identifier>ISSN: 1545-9993</identifier><identifier>EISSN: 1545-9985</identifier><identifier>DOI: 10.1038/s41594-022-00725-7</identifier><identifier>PMID: 35165457</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>101/28 ; 631/45/500 ; 631/535/1258/1259 ; 631/535/1266 ; Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Antibiotics ; Bacteria - drug effects ; Bacteria - genetics ; Bacteria - metabolism ; Biochemistry ; Biological Microscopy ; Biomedical and Life Sciences ; Chloramphenicol ; Chloramphenicol - chemistry ; Chloramphenicol - pharmacology ; Chloromycetin ; Context ; Drug Development ; Drug Resistance, Bacterial - genetics ; Humans ; Life Sciences ; Linezolid ; Linezolid - chemistry ; Linezolid - pharmacology ; Membrane Biology ; Models, Molecular ; News & Views ; news-and-views ; Oxazolidinones ; Oxazolidinones - chemistry ; Oxazolidinones - pharmacology ; Protein biosynthesis ; Protein Biosynthesis - drug effects ; Protein Structure ; Protein synthesis ; Protein Synthesis Inhibitors - chemistry ; Protein Synthesis Inhibitors - pharmacology ; Ribosomes - drug effects ; Ribosomes - metabolism ; Structure-Activity Relationship</subject><ispartof>Nature structural & molecular biology, 2022-02, Vol.29 (2), p.79-81</ispartof><rights>Springer Nature America, Inc. 2022</rights><rights>Springer Nature America, Inc. 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-35c2ddc791316fd4f9de59255b3d08bc5b257582cfa6c19e960baa7330586e5b3</citedby><cites>FETCH-LOGICAL-c375t-35c2ddc791316fd4f9de59255b3d08bc5b257582cfa6c19e960baa7330586e5b3</cites><orcidid>0000-0003-3816-3828</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41594-022-00725-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41594-022-00725-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35165457$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Crowe-McAuliffe, Caillan</creatorcontrib><creatorcontrib>Wilson, Daniel N.</creatorcontrib><title>Putting the antibiotics chloramphenicol and linezolid into context</title><title>Nature structural & molecular biology</title><addtitle>Nat Struct Mol Biol</addtitle><addtitle>Nat Struct Mol Biol</addtitle><description>Growing evidence suggests that many ribosome-targeting antibiotics inhibit protein synthesis context specifically, which has important implications for drug development. New work reveals the structural basis of context-specific action of the classic translation inhibitor chloramphenicol and the oxazolidinones linezolid and radezolid.</description><subject>101/28</subject><subject>631/45/500</subject><subject>631/535/1258/1259</subject><subject>631/535/1266</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Bacteria - drug effects</subject><subject>Bacteria - genetics</subject><subject>Bacteria - metabolism</subject><subject>Biochemistry</subject><subject>Biological Microscopy</subject><subject>Biomedical and Life Sciences</subject><subject>Chloramphenicol</subject><subject>Chloramphenicol - chemistry</subject><subject>Chloramphenicol - pharmacology</subject><subject>Chloromycetin</subject><subject>Context</subject><subject>Drug Development</subject><subject>Drug Resistance, Bacterial - genetics</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Linezolid</subject><subject>Linezolid - chemistry</subject><subject>Linezolid - pharmacology</subject><subject>Membrane Biology</subject><subject>Models, Molecular</subject><subject>News & Views</subject><subject>news-and-views</subject><subject>Oxazolidinones</subject><subject>Oxazolidinones - chemistry</subject><subject>Oxazolidinones - pharmacology</subject><subject>Protein biosynthesis</subject><subject>Protein Biosynthesis - drug effects</subject><subject>Protein Structure</subject><subject>Protein synthesis</subject><subject>Protein Synthesis Inhibitors - chemistry</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>Ribosomes - drug effects</subject><subject>Ribosomes - metabolism</subject><subject>Structure-Activity Relationship</subject><issn>1545-9993</issn><issn>1545-9985</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kM1PwyAchonRuDn9BzyYJl68VPkoUI66-JUs0YOeCaV0Y-lgFpqof724zpl48ATJ-_xefjwAnCJ4iSApr0KBqChyiHEOIcc053tgjGhBcyFKur-7CzICRyEsIcSUcnIIRoQiljI-BjfPfYzWzbO4MJly0VbWR6tDphet79RqvTDOat-mrM5a68ynb22dWRd9pr2L5j0eg4NGtcGcbM8JeL27fZk-5LOn-8fp9SzXhNOYE6pxXWsuEEGsqYtG1IaKtFFFalhWmlaYclpi3SimkTCCwUopTgikJTOJmoCLoXfd-bfehChXNmjTtsoZ3weJGRYwfZCVCT3_gy5937m03YZCDDMGE4UHSnc-hM40ct3Zleo-JILy27AcDMtkWG4MS56GzrbVfbUy9W7kR2kCyACEFLm56X7f_qf2C43fhgQ</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Crowe-McAuliffe, Caillan</creator><creator>Wilson, Daniel N.</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PADUT</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3816-3828</orcidid></search><sort><creationdate>20220201</creationdate><title>Putting the antibiotics chloramphenicol and linezolid into context</title><author>Crowe-McAuliffe, Caillan ; Wilson, Daniel N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-35c2ddc791316fd4f9de59255b3d08bc5b257582cfa6c19e960baa7330586e5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>101/28</topic><topic>631/45/500</topic><topic>631/535/1258/1259</topic><topic>631/535/1266</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Bacteria - drug effects</topic><topic>Bacteria - genetics</topic><topic>Bacteria - metabolism</topic><topic>Biochemistry</topic><topic>Biological Microscopy</topic><topic>Biomedical and Life Sciences</topic><topic>Chloramphenicol</topic><topic>Chloramphenicol - chemistry</topic><topic>Chloramphenicol - pharmacology</topic><topic>Chloromycetin</topic><topic>Context</topic><topic>Drug Development</topic><topic>Drug Resistance, Bacterial - genetics</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Linezolid</topic><topic>Linezolid - chemistry</topic><topic>Linezolid - pharmacology</topic><topic>Membrane Biology</topic><topic>Models, Molecular</topic><topic>News & Views</topic><topic>news-and-views</topic><topic>Oxazolidinones</topic><topic>Oxazolidinones - chemistry</topic><topic>Oxazolidinones - pharmacology</topic><topic>Protein biosynthesis</topic><topic>Protein Biosynthesis - drug effects</topic><topic>Protein Structure</topic><topic>Protein synthesis</topic><topic>Protein Synthesis Inhibitors - chemistry</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>Ribosomes - drug effects</topic><topic>Ribosomes - metabolism</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crowe-McAuliffe, Caillan</creatorcontrib><creatorcontrib>Wilson, Daniel N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Research Library China</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature structural & molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crowe-McAuliffe, Caillan</au><au>Wilson, Daniel N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Putting the antibiotics chloramphenicol and linezolid into context</atitle><jtitle>Nature structural & molecular biology</jtitle><stitle>Nat Struct Mol Biol</stitle><addtitle>Nat Struct Mol Biol</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>29</volume><issue>2</issue><spage>79</spage><epage>81</epage><pages>79-81</pages><issn>1545-9993</issn><eissn>1545-9985</eissn><abstract>Growing evidence suggests that many ribosome-targeting antibiotics inhibit protein synthesis context specifically, which has important implications for drug development. New work reveals the structural basis of context-specific action of the classic translation inhibitor chloramphenicol and the oxazolidinones linezolid and radezolid.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>35165457</pmid><doi>10.1038/s41594-022-00725-7</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-3816-3828</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1545-9993 |
| ispartof | Nature structural & molecular biology, 2022-02, Vol.29 (2), p.79-81 |
| issn | 1545-9993 1545-9985 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2629055768 |
| source | MEDLINE; Springer Nature - Complete Springer Journals; Nature |
| subjects | 101/28 631/45/500 631/535/1258/1259 631/535/1266 Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Antibiotics Bacteria - drug effects Bacteria - genetics Bacteria - metabolism Biochemistry Biological Microscopy Biomedical and Life Sciences Chloramphenicol Chloramphenicol - chemistry Chloramphenicol - pharmacology Chloromycetin Context Drug Development Drug Resistance, Bacterial - genetics Humans Life Sciences Linezolid Linezolid - chemistry Linezolid - pharmacology Membrane Biology Models, Molecular News & Views news-and-views Oxazolidinones Oxazolidinones - chemistry Oxazolidinones - pharmacology Protein biosynthesis Protein Biosynthesis - drug effects Protein Structure Protein synthesis Protein Synthesis Inhibitors - chemistry Protein Synthesis Inhibitors - pharmacology Ribosomes - drug effects Ribosomes - metabolism Structure-Activity Relationship |
| title | Putting the antibiotics chloramphenicol and linezolid into context |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T15%3A15%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Putting%20the%20antibiotics%20chloramphenicol%20and%20linezolid%20into%20context&rft.jtitle=Nature%20structural%20&%20molecular%20biology&rft.au=Crowe-McAuliffe,%20Caillan&rft.date=2022-02-01&rft.volume=29&rft.issue=2&rft.spage=79&rft.epage=81&rft.pages=79-81&rft.issn=1545-9993&rft.eissn=1545-9985&rft_id=info:doi/10.1038/s41594-022-00725-7&rft_dat=%3Cproquest_cross%3E2629162660%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2629162660&rft_id=info:pmid/35165457&rfr_iscdi=true |